AMD3100 plus G-CSF use in proven poor mobilizers in a compassionate use protocol (CUP).

被引：1
|
作者：
McGuirk, J
McCarty, J
Gibb, K
Badel, K
Bridger, G
Calandra, G
机构：
[1] Kansas City Canc Ctr, BMT Program, Kansas City, MO USA
[2] Virginia Commonwealth Univ, BTM Program, Massey Canc Ctr, Richmond, VA USA
[3] AnorMED Inc, Langley, BC, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.154.154
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
154
引用
收藏
页码：49A / 49A
页数：1
相关论文
共 50 条
  • [1] AMD3100 plus G-CSF use in 100 proven poor mobilisers in a compassionate use protocol
    McCarty, J
    McGuirk, J
    Grove, B
    Badel, K
    Olsen, H
    Bridger, G
    Calandra, G
    BONE MARROW TRANSPLANTATION, 2006, 37 : S36 - S36
  • [2] Single-center experience with the early use of AMD3100 plus G-CSF for mobilization of hematopoietic progenitor cells in patients classified as poor mobilizers
    Roberts, C. H.
    Chung, H. M.
    Candler, K. S.
    Calandra, G.
    Badel, K.
    McCarty, J. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 39 - 39
  • [3] The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
    Flomenberg, N
    Devine, SM
    DiPersio, JF
    Liesveld, JL
    McCarty, JM
    Rowley, SD
    Vesole, DH
    Badel, K
    Calandra, G
    BLOOD, 2005, 106 (05) : 1867 - 1874
  • [4] AMD3100 and G-CSF for poor mobilisers; successful harvest of stem cells in a child with cancer
    Bateman, CM
    Stephen, K
    Calandra, G
    Shaw, PJ
    BONE MARROW TRANSPLANTATION, 2005, 35 : S105 - S105
  • [5] Evaluation of the phenotype and GVHD-inducing potential of splenic T cells isolated from G-CSF, AMD3100, or G-CSF and AMD3100 pretreated allogeneic donors
    Rettig, M
    Holt, M
    Liu, FL
    Ritchey, J
    Link, D
    Bridger, G
    DiPersio, J
    BLOOD, 2005, 106 (11) : 389B - 390B
  • [6] The effect of rituximab on mobilization with AMD3100 plus G-CSF in patients with relapsed or refractory NHL or HD
    Kaufman, Jonathan. L.
    Cook, Amanda M.
    Flowers, Christopher
    Langston, Amelia A.
    Lonial, Sagar
    Lechowicz, Mary Jo
    Khoury, H. Jean
    Calandra, Gary
    Waller, Ned
    BLOOD, 2007, 110 (11) : 568A - 568A
  • [7] AMD3100 IN COMBINATION WITH G-CSF RESTORES THE IMPAIRED MOBILIZATION WITH G-CSF ALONE IN THE THALASSEMIC MOUSE MODEL
    Yannaki, E.
    Psatha, N.
    Demertzi, M.
    Athanasiou, E.
    Bougiouklis, D.
    Arsenakis, M.
    Anagnostopoulos, A.
    Fassas, A.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S81 - S81
  • [8] Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants?
    Shen, Zhao-Hua
    Zeng, Dong-Feng
    Ma, Ying-ying
    Zhang, Xi
    Zhang, Cheng
    Kong, Pei-Yan
    MEDICAL ONCOLOGY, 2015, 32 (12)
  • [9] Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants?
    Zhao-Hua Shen
    Dong-Feng Zeng
    Ying-ying Ma
    Xi Zhang
    Cheng Zhang
    Pei-Yan Kong
    Medical Oncology, 2015, 32
  • [10] AMD3100 and G-CSF mobilize angiogenic cells into the blood of healthy donors.
    Shepherd, RM
    Capoccia, BJ
    Devine, SM
    Ingram, DA
    Link, DC
    BLOOD, 2005, 106 (11) : 846A - 846A
12345